Pernix Therapeutics Files Chapter 11 Bankruptcy in Delaware

Feb. 19, 2019, 4:30 PM UTC

Pharmaceutical manufacturer Pernix Therapeutics Holdings Inc. filed for Chapter 11 protection in U.S. Bankruptcy Court for the District of Delaware, court filings show.

The New Jersey-headquartered company has estimated liabilities of $100 million to $500 million, and estimated assets of $100 million to $500 million, according to the filing.

Adam G. Landis , of Landis Rath & Cobb LLP in Wilmington, Del., filed the petition.

©2019 Bloomberg L.P. All rights reserved. Used with permission

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.